• 1
    United Kingdom National Screening Committee. Antenatal screening–working standards for Down's syndrome screening. 2007.
  • 2
    American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 77: screening for fetal chromosomal abnormalities. Obstet Gynecol 2007;109:21727.
  • 3
    Nicolaides KH. Screening for fetal aneuploidies at 11 to 13 weeks. Prenat Diagn 2011;31:715.
  • 4
    Alfirevic Z, Gosden CM, Neilson JP. Chorion villus sampling versus amniocentesis for prenatal diagnosis. Cochrane Database Syst Rev 2000;2:CD000055.
  • 5
    Tabor A, Alfirevic Z. Update on procedure-related risks for prenatal diagnosis techniques. Fetal Diagn Ther 2010;27:17.
  • 6
    Chiu RW, Akolekar R, Zheng YW, Leung TY, Sun H, Chan KC, et al. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. BMJ 2011;342:c7401.
  • 7
    Sehnert AJ, Rhees B, Comstock D, de Feo E, Heilek G, Burke J, et al. Optimal detection of fetal chromosomal abnormalities by massively parallel DNA sequencing of cell-free fetal DNA from maternal blood. Clin Chem 2011;57:10429.
  • 8
    Palomaki GE, Kloza EM, Lambert-Messerlian GM, Haddow JE, Neveux LM, Ehrich M, et al. DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med 2011;13:91320.
  • 9
    Nicolaides KH, Syngelaki A, Ashoor G, Birdir C, Touzet G. Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population. Am J Obstet Gynecol 2012;207:374.e16.
  • 10
    Ehrich M, Deciu C, Zwiefelhofer T, Tynan JA, Cagasan L, Tim R, et al. Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. Am J Obstet Gynecol 2011;204:205.e111.
  • 11
    Bianchi DW, Platt LD, Goldberg JD, Abuhamad AZ, Sehnert AJ, Rava RP. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol 2012;119:890901.
  • 12
    Palomaki GE, Deciu C, Kloza EM, Lambert-Messerlian GM, Haddow JE, Neveux LM, et al. DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study. Genet Med 2012;14:296305.
  • 13
    Norton ME, Brar H, Weiss J, Karimi A, Laurent LC, Caughey AB, et al. Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012;207:137.e18.
  • 14
    Ashoor G, Syngelaki A, Wang E, Struble C, Oliphant A, Song K, et al. Trisomy 13 detection in the first trimester of pregnancy using a chromosome-selective cell-free DNA analysis method. Ultrasound Obstet Gynecol 2013;41:215.
  • 15
    The American College of Obstetricians and Gynecologists Committee on Genetics. Noninvasive prenatal testing for aneuploidy – Committee opinion. Obstet Gynecol. 2012;120:15324.
  • 16
    Gregg AR, Gross SJ, Best RG, Monaghan KG, Bajaj K, Skotko BG, et al. ACMG statement on noninvasive prenatal screening for fetal aneuploidy. Genet Med 2013;15:3958.
  • 17
    Chitty LS, Hill M, White H, Wright D, Morris S. Noninvasive prenatal testing for aneuploidy-ready for prime time? Am J Obstet Gynecol 2012;206:26975.
  • 18
    Hall A, Bostanci A, Wright CF. Non-invasive prenatal diagnosis using cell-free fetal DNA technology: applications and implications. Public Health Genomics 2010;13:24655.
  • 19
    Morris S, Karlsen S, Chung N, Hill M, Chitty L. Model-based analysis of costs and outcomes of non-invasive prenatal testing for Down's syndrome using cell free fetal DNA Submitted. 2013.
  • 20
    Kelly SE, Farrimond HR. Non-invasive prenatal genetic testing: a study of public attitudes. Public health genomics. 2012;15:7381.
  • 21
    Lewis C, Silcock C, Chitty LS. Non-invasive prenatal testing for Down's syndrome – pregnant women's views and likely uptake. Public Health Genomics 2013;16:22332.
  • 22
    Raymond MR, Roberts DM. A comparison of methods for treating incomplete data in selection research. Educ Psychol Meas 1987;47:1326.
  • 23
    Kleinveld JH, van den Berg M, van Eijk JT, van Vugt JM, van der Wal G, Timmermans DR. Does offering prenatal screening influence pregnant women's attitudes regarding prenatal testing? Community Genet 2008;11:36874.
  • 24
    Tischler R, Hudgins L, Blumenfeld YJ, Greely HT, Ormond KE. Noninvasive prenatal diagnosis: pregnant women's interest and expected uptake. Prenat Diagn 2011;26:12929.
  • 25
    UK National Screening Committee Screening in England 2010–11 Annual Report. Annual Report: UK National Screening Committee; 2011.
  • 26
    Morris JK, Waters JJ, de Souza E. The population impact of screening for Down syndrome: audit of 19 326 invasive diagnostic tests in England and Wales in 2008. Prenat Diagn 2012;32:596601.
  • 27
    Lewis C, Hill M, Chitty L. Non-invasive prenatal diagnosis for single gene disorders: experience of patients. Clin Genet 2013;doi: 10.1111/cge12179.
  • 28
    Lewis C, Hill M, Skirton H, Chitty L. Non-invasive prenatal diagnosis for fetal sex determination – benefits and disadvantages from the service users' perspective. Eur J Hum Genet 2012;20:112733.
  • 29
    Zamerowski ST, Lumley MA, Arreola RA, Dukes K, Sullivan L. Favorable attitudes toward testing for chromosomal abnormalities via analysis of fetal cells in maternal blood. Genet Med 2001;3:3019.
  • 30
    Chetty S, Garabedian MJ, Norton ME. Uptake of noninvasive prenatal testing (NIPT) in women following positive aneuploidy screening. Prenat Diagn 2013;33:5426.
  • 31
    Taylor JB, Chock VY, Hudgins L. NIPT in a Clinical Setting: an analysis of Uptake in the First Months of Clinical Availability. J Genet Couns 2013; [forthcoming].
  • 32
    Vahanian SA, Allaf MB, Yeh C, Chavez MR, Kinzler WL, Vintzileos AM. Patient acceptance of non-invasive testing for fetal aneuploidy via cell-free fetal DNA. J Maternal Fetal Neonatal Med 2013;27:1099.
  • 33
    Greely HT. Get ready for the flood of fetal gene screening. Nature 2011;469:28991.
  • 34
    Verweij EJ, Oepkes D, de BM. Changing attitudes towards termination of pregnancy for trisomy 21 with non-invasive prenatal trisomy testing: a population-based study in Dutch pregnant women. Prenat Diagn 2013;33:3979.
  • 35
    Markens S, Browner CH, Press N. ‘Because of the risks’: how US pregnant women account for refusing prenatal screening. Soc Sci Med 1999;49:35969.
  • 36
    Gottfredsdottir H, Bjornsdottir K, Sandall J. How do prospective parents who decline prenatal screening account for their decision? A qualitative study Soc Sci Med 2009;69:2747.
  • 37
    Morris JK, Alberman E. Trends in Down's syndrome live births and antenatal diagnoses in England and Wales from 1989 to 2008: analysis of data from the National Down Syndrome Cytogenetic Register. BMJ 2009;339:b3794.
  • 38
    Leung TN, Ching CM, Chang JJ, Leung TY, Fung TY, Lau TK. Attitudes towards termination of pregnancy among Hong Kong Chinese women attending prenatal diagnosis counselling clinic. Prenat Diagn 2004;24:54651.
  • 39
    Bryant L, Hewison JD, Green JM. Attitudes towards prenatal diagnosis and termination in women who have a sibling with Down's syndrome. J Reprod Infant Psychol 2005;23:18198.
  • 40
    Britt DW, Risinger ST, Miller V, Mans MK, Krivchenia EL, Evans MI. Determinants of parental decisions after the prenatal diagnosis of down syndrome: bringing in context. Am J Med Genet 2000;5:41016.
  • 41
    Dzurova D, Pikhart H. Down syndrome, paternal age and education: comparison of California and the Czech Republic. BMC Public Health 2005;17:69.
  • 42
    Hill M, Fisher J, Chitty LS, Morris S. Women's and health professionals' preferences for prenatal tests for Down syndrome: a discrete choice experiment to contrast noninvasive prenatal diagnosis with current invasive tests. Genet Med 2012;14:90513.
  • 43
    Silcock C, Liao L-M, Hill M, Chitty L. Will the introduction of noninvasive prenatal testing for Down's syndrome undermine informed choice: a questionnaire study. 2013; [forthcoming].
  • 44
    van den Heuvel A, Chitty L, Dormandy E, Newson A, Deans Z, Attwood S, et al. Will the introduction of non-invasive prenatal diagnostic testing erode informed choices? An experimental study of health care professionals. Patient Educ Couns 2009;78:248.
  • 45
    Garcia J, Bricker L, Henderson J, Martin MA, Mugford M, Nielson J, et al. Women's views of pregnancy ultrasound: a systematic review. Birth 2002;29:22550.
  • 46
    Goldsmith L, Jackson L, O'Connor A, Skirton H. Direct-to-consumer genomic testing: systematic review of the literature on user perspectives. Eur J Hum Genet 2012;20:81116.
  • 47
    Skirton H, Goldsmith L, Jackson L, O'Connor A. Direct to consumer genetic testing: a systematic review of position statements, policies and recommendations. Clin Genet 2012;82:21018.
  • 48
    Hill M, Karunaratna M, Lewis C, Forya F, Chitty L. Views and preferences for the implementation of non-invasive prenatal diagnosis for single gene disorders from health professionals in the united kingdom. Am J Med Genet A 2013;161A:16128.